Plasma concentrations of diphenylhydantoin, its para-hydroxylated metabolite, and corresponding glucuronide in man
Albert, K.S.; Hallmark, M.R.; Sakmar, E.; Weidler, D.J.; Wagner, J.G.
Research Communications in Chemical Pathology and Pharmacology 9(3): 463-469
1974
ISSN/ISBN: 0034-5164 PMID: 4445566 Document Number: 72292
Document emailed within 1 workday
Related Documents
Gluth, W.P.; Sörgel, F. 1991: Determination of oxprenolol and its glucuronide metabolite in plasma and urine using high-performance liquid chromatography Die Pharmazie 46(5): 336-339Löscher, W.; Ganter, M.; Fassbender, C.P. 1990: Correlation between drug and metabolite concentrations in plasma and anesthetic action of ketamine in swine American Journal of Veterinary Research 51(3): 391-398
Schröder, H.; Schröder, B.M. 1973: Isolation and determination of a hydroxylated metabolite of sulphapyridine from human urine Acta Pharmaceutica Suecica 10(4): 263-268
Calvey, T.N.; Back, D.J. 1973: Biliary excretion of 14 C-edrophonium and its glucuronide metabolite in Gunn rats Archives Internationales de Pharmacodynamie et de Therapie 201(1): 147-153
Preston, A.M.; Bercovitch, F.B.; Jimenez, B.D.; Rodriguez Orengo, J.F.; Morales, W.Delgado.; Rodriguez, C.A.; Lebron, M.R.; Rivera, C.E. 2002: Plasma homocysteine concentrations in a population of rhesus monkeys (Macaca mulatta): reference ranges and accompanying plasma concentrations of folate and vitamin B12 Contemporary Topics in Laboratory Animal Science 41(1): 28-30
Pakszys, W. 1971: Effect of 5,5-diphenylhydantoin and pneumoencephalography on urinary excretion of 5-hydroxyindoloacetic acid, a serotonin metabolite, and serum ceruloplasmin activity in epileptics Neurologia i Neurochirurgia Polska 5(3): 311-316
Hande, K.; Anthony, L.; Hamilton, R.; Bennett, R.; Sweetman, B.; Branch, R. 1988: Identification of etoposide glucuronide as a major metabolite of etoposide in the rat and rabbit Cancer Research 48(7): 1829-1834
Stavchansky, S.A.; Kostenbauder, H.B.; Lubawy, W.C. 1975: Kinetic and spectral studies of type i and type Ii compounds with rat hepatic microsomes in the presence of the major metabolite of diphenylhydantoin Drug Metabolism and Disposition: the Biological Fate of Chemicals 3(6): 557-564
Gerardy, B.M.; Kapusta, D.; Dumont, P.; Poupaert, J.H. 1986: Synthesis, characterization, and quantitation of para-hydroxymethadone, a metabolite of methadone in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(4): 477-481
Lubawy, W.C.; Kostenbauder, H.B.; Stavchansky, S.A. 1974: Cross inhibition of drug metabolism by drug metabolites. Increase of zoxazolamine paralysis time by the major metabolite of diphenylhydantoin Research Communications in Chemical Pathology and Pharmacology 8(1): 75-82
Uchihashi, Y.; Kuribara, H.; Morita, T.; Kitani, Y.; Karasawa, F.; Sato, T. 1996: Differential effects of morphine-6-glucuronide, an active metabolite of morphine, and morphine on locomotor activity in mice: involvement of the opioid receptor Pharmacology and Toxicology 78(5): 322-326
Meyer, F.P.; Walther, H.; Quednow, B. 1977: Binding of diphenylhydantoin and phenobarbital to serum proteins in therapeutical relevant concentrations in the newborn infants and adults Padiatrie und Grenzgebiete 16(1): 1-7
Thomassen, D.; Pearson, P.G.; Slattery, J.T.; Nelson, S.D. 1991: Partial characterization of biliary metabolites of pulegone by tandem mass spectrometry. Detection of glucuronide, glutathione, and glutathionyl glucuronide conjugates Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(5): 997-1003
Laug, W.E.; Siegel, S.E.; Shaw, K.N.; Landing, B.; Baptista, J.; Gutenstein, M. 1978: Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma Pediatrics 62(1): 77-83
Day, R.O.; Francis, H.; Vial, J.; Geisslinger, G.; Williams, K.M. 1995: Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations Journal of Rheumatology 22(12): 2295-2303
Lapicque, F.; Bertin, P.; Netter, P. 1996: Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations Journal of Rheumatology 23(10): 1826-7; Author Reply 1827-8
Pollak, P.T. 2001: Altered metabolite concentrations with amiodarone generic substitution cannot be observed without monitoring Canadian Journal of Cardiology 17(11): 1159-1163
Zaccara, G.; Galli, A.; Rossi, L.; Zappoli, R.; Zatelli, L.; Amaducci, L. 1977: Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment Rivista di Patologia Nervosa E Mentale 98(6): 363-375
Franks, S.E.; Kuesel, A.C.; Lutz, N.W.; Hull, W.E. 1996: 31P MRS of human tumor cells: effects of culture media and conditions on phospholipid metabolite concentrations Anticancer Research 16(3b): 1365-1374
Liu, J.H.; Malone, R.S.; Stallings, H.; Smith, P.C. 1996: Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins Journal of Pharmacology and Experimental Therapeutics 278(1): 277-283